Accordingly, genetic or pharmacologic blockade of either SLC1A5 or GLS impaired ATP production, cell proliferation and neuroendocrine differentiation observed in CAF-activated PCa cells. The gene discussed is GLS; the disease is posterior cortical atrophy.